U.S. international reference pricing: Global implications and pharma strategy Blog Post
Unintended global fallout of international reference pricing: How the U.S. Most Favored Nation policy could reshape drug pricing, access and industry strategy
Streamline clinical data publication under EMA policy 0070 Blog Post
Policy 0070 is restarting requiring early submission preparation. Learn about clinical data publication, new timelines, anonymization reports & compliance.
Medtech market access: why strategy can’t wait for regulatory approval Blog Post
Medtech market access strategy must start long before approval. See how medical device reimbursement pathways differ & what payers really want to see
